1. Home
  2. INSM vs DEO Comparison

INSM vs DEO Comparison

Compare INSM & DEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$176.09

Market Cap

41.2B

Sector

Health Care

ML Signal

HOLD

Logo Diageo plc

DEO

Diageo plc

HOLD

Current Price

$86.99

Market Cap

47.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSM
DEO
Founded
1988
1886
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
41.2B
47.6B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
INSM
DEO
Price
$176.09
$86.99
Analyst Decision
Strong Buy
Buy
Analyst Count
21
2
Target Price
$185.84
$109.00
AVG Volume (30 Days)
3.8M
1.7M
Earning Date
02-19-2026
02-03-2026
Dividend Yield
N/A
4.72%
EPS Growth
N/A
N/A
EPS
N/A
1.06
Revenue
$447,022,000.00
$20,245,000,000.00
Revenue This Year
$43.95
$2.58
Revenue Next Year
$130.35
$3.33
P/E Ratio
N/A
$81.62
Revenue Growth
30.34
N/A
52 Week Low
$60.40
$85.12
52 Week High
$212.75
$127.33

Technical Indicators

Market Signals
Indicator
INSM
DEO
Relative Strength Index (RSI) 39.45 44.46
Support Level $173.24 $85.48
Resistance Level $179.44 $86.94
Average True Range (ATR) 5.92 1.18
MACD -1.75 0.09
Stochastic Oscillator 32.48 39.02

Price Performance

Historical Comparison
INSM
DEO

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About DEO Diageo plc

Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio. The firm has also shed noncore brands over the years, including the majority of its wine assets in 2015.

Share on Social Networks: